Release Date: 31/05/11 13:24 Summary: Results of Annual General Meeting Price Sensitive: No Download Document 429.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%